Prevalence of Chronic Kidney Disease in US Adults with Undiagnosed Diabetes or Prediabetes
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVES: Prevalence of chronic kidney disease (CKD) in people with diagnosed diabetes is known to be high, but little is known about the prevalence of CKD in those with undiagnosed diabetes or prediabetes. We aimed to estimate and compare the community prevalence of CKD among people with diagnosed diabetes, undiagnosed diabetes, prediabetes, or no diabetes. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The 1999 through 2006 National Health and Nutrition Examination Survey is a representative survey of the civilian, noninstitutionalized US population. Participants who were aged > or =20 years; responded to the diabetes questionnaire; and had fasting plasma glucose (FPG), serum creatinine, and urinary albumin-creatinine ratio measurements were included (N = 8188). Diabetes status was defined as follows: Diagnosed diabetes, self-reported provider diagnosis (n = 826); undiagnosed diabetes, FPG > or =126 mg/dl without self-reported diagnosis (n = 299); prediabetes, FPG > or =100 and <126 mg/dl (n = 2272); and no diabetes, FPG <100 mg/dl (n = 4791). Prevalence of CKD was defined by estimated GFR 15 to 59 ml/min per 1.73 m(2) or albumin-creatinine ratio > or =30 mg/g; adjustment was performed with multivariable logistic regression. RESULTS: Fully 39.6% of people with diagnosed and 41.7% with undiagnosed diabetes had CKD; 17.7% with prediabetes and 10.6% without diabetes had CKD. Age-, gender-, and race/ethnicity-adjusted prevalence of CKD was 32.9, 24.2, 17.1, and 11.8%, for diagnosed, undiagnosed, pre-, and no diabetes, respectively. Among those with CKD, 39.1% had undiagnosed or prediabetes. CONCLUSIONS: CKD prevalence is high among people with undiagnosed diabetes and prediabetes. These individuals might benefit from interventions aimed at preventing development and/or progression of both CKD and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, evidence of a cross-sectional association between prediabetes and eGFR, a late marker of CKD, is mixed, including both studies with positive54 and null findings.55,57”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [54]
Experimental — accuracy not yet measuredIn the citing paper
“The NHANES 1999–2006 showed increasing frequency of albuminuria in tandem with the glycaemia range when classified from normoglycaemia through IFG, undiagnosed diabetes and diagnosed diabetes for both microalbuminuria, which may also relate to hypertension and is therefore an imprecise marker of diabetes-related early nephropathy (6%, 10%, 29% and 29%, respectively) and macroalbuminuria (0.6%, 1.1”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [54]
In the citing paper
“There is evidence to link prediabetes to increased risk of early forms of nephropathy and chronic kidney disease (CKD), defined based on methods such as urinary albumin excretion rate (AER) and estimated glomerular filtration rate (eGFR).51–55”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Self-citationDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725 · cited 9×
“The unadjusted CKD prevalence using the MDRD Study equation (7) was 39.6 and 41.7% in those with diagnosed and undiagnosed diabetes, respectively (Figure 1A).”
MethodInfluentialSelf-citationBasevi, V., Di Mario, S., Morciano, C., Nonino, F., & Magrini, N. (2011) · Diabetes Care · doi:10.2337/dc11-0174 · Cited by 3,055
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006
Cowie, C. C., Rust, K. F., Ford, E. S., Eberhardt, M. S., Byrd-Holt, D. D., Li, C., Williams, D. E., Gregg, E. W., Bainbridge, K. E., Saydah, S. H., et al. (2009) · Diabetes Care · doi:10.2337/dc08-1296 · Cited by 1,154
Self-citationChronic Kidney Disease Awareness, Prevalence, and Trends among U.S. Adults, 1999 to 2000
Coresh, J., Byrd-Holt, D., Astor, B. C., Briggs, J. P., Eggers, P. W., Lacher, D. A., & Hostetter, T. H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070539 · Cited by 842
Self-citationKramer, H. J. (2003) · JAMA · doi:10.1001/jama.289.24.3273 · Cited by 618 · cited 1×
“We defined CKD as either reduced kidney function or elevated albuminuria, because reduced kidney function may occur even in the absence of albuminuria in those with type 2 diabetes (5,6).”
BackgroundImprovements in Diabetes Processes of Care and Intermediate Outcomes: United States, 1988–2002
Saaddine, J. B., Cadwell, B., Gregg, E. W., Engelgau, M. M., Vinicor, F., Imperatore, G., & Narayan, K. M. V. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-7-200604040-00005 · Cited by 571
Research works printed but not linked: 3
- US Renal Data System: USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009 [Google Scholar]
- Centers for Disease Control and Prevention: National diabetes fact sheet: General information and national estimates on diabetes in the United States, 2007, Atlanta, US Department of Health and Human Services, Centers for Disease Control and Prevention, 2008. Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf Accessed February 1, 2009 [Google Scholar]
- Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290: 2159–2167, 2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
Cited by
Items 101–200 of 421
Pal, K., Horsfall, L., Sharma, M., Nazareth, I., & Petersen, I. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001989 · Cited by 37
Mendy, V. L., Azevedo, M. J., Sarpong, D. F., Rosas, S. E., Ekúndayò, O. T., Sung, J. H., Bhuiyan, A. R., Jenkins, B. C., & Addison, C. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101610 · Cited by 38
“There is a gap in awareness of the condition among high risk adults [2], particularly minority populations [3].”
BackgroundRenal Dysfunction in Prediabetes: Confirmed by Glomerular Hyperfiltration and Albuminuria
Shilpasree, A. S., Patil, V. S., Revanasiddappa, M., Patil, V. P., & Ireshnavar, D. (2021) · Journal of Laboratory Physicians · doi:10.1055/s-0041-1731107 · Cited by 36
Association between sarcopenia and prediabetes among non-elderly US adults
Xu, J., Han, X., Chen, Q., Cai, M., Tian, J., Yan, Z., Guo, Q., Xu, J., & Lü, H. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02038-y · Cited by 35
Ishigami, J., Sang, Y., Grams, M. E., Coresh, J., Chang, A. R., & Matsushita, K. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.09.008 · Cited by 35
Self-citationCeriello, A., & Inagaki, N. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12528 · Cited by 33
“The development of moderate-to-severe renal impairment (de fi ned as an estimated glomerular fi ltration rate [eGFR] below 60 mL/min/1.73 m 2 ) is a frequent complication of type 2 diabetes mellitus, and some degree of renal disease is estimated to be present in up to 40% of patients 45 – 47 .”
InfluentialKhunti, K., Morris, D. H., Weston, C. L., Gray, L. J., Webb, D. R., & Davies, M. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055580 · Cited by 37
“This estimate is much lower than that observed in other studies [20,21].”
ResultInagaki, N., Kondo, K., Yoshinari, T., Ishii, M., Sakai, M., Kuki, H., & Furihata, K. (2014) · Clinical Drug Investigation · doi:10.1007/s40261-014-0226-x · Cited by 31
“7 % in those with undiagnosed diabetes [4].”
BackgroundMoving closer to understanding the risks of living kidney donation
Steiner, R. W. (2015) · Clinical Transplantation · doi:10.1111/ctr.12652 · Cited by 32
Caffeine consumption and mortality in chronic kidney disease: a nationally representative analysis
Vieira, M. B., Magriço, R., Dias, C. V., Leitão, L., & Neves, J. S. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy234 · Cited by 31
Daniele, G., Winnier, D. A., Mari, A., Bruder, J., Fourcaudot, M. J., Zuo, P., HANSIS-DIARTE, A. A., Jenkinson, C. P., Tripathy, D., & Folli, F. B. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-1065-z · Cited by 31
Siriwardhana, C., Lim, E., Davis, J. W., & Chen, J. J. (2018) · BMC Public Health · doi:10.1186/s12889-018-5688-y · Cited by 29
“undiagnosed diabetes and pre-diabetes [12].”
Lee, J., Kang, H., Lim, H.-J., & Park, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.01.013 · Cited by 29
Fukushima, T., Chubachi, S., Namkoong, H., Asakura, T., Tanaka, H., Lee, H., Azekawa, S., Okada, Y., Koike, R., Kimura, A., et al. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14857 · Cited by 30
Dissanayake, A. M., Wheldon, M. C., Ahmed, J., & Hood, C. J. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.03.005 · Cited by 30
“T ype 2 diabetes is increasingly the most prevalent cause of chronic kidney disease (CKD) worldwide, with a lifetime prevalence of nephropathy of w40%.(1) Metformin is a time-tested medication in the treatment of type 2 diabetes and is the recommended firstline drug in almost all practice guidelines.”
BackgroundClinical Manifestations and Natural History of Diabetic Kidney Disease
Ritz, E. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.10.008 · Cited by 29
Müller‐Wieland, D., Merkel, M., Hamann, A., Siegel, E. G., Ottillinger, B., Woker, R., & Fresenius, K. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13273 · Cited by 27
Trends in estimated kidney function: the FINRISK surveys
Juutilainen, A., Kastarinen, H., Antikaínen, R., Peltonen, M., Salomaa, V. V., Tuomilehto, J., Jousilahti, P., Sundvall, J., Laatikainen, T. K., & Kastarinen, M. J. (2012) · European Journal of Epidemiology · doi:10.1007/s10654-012-9652-3 · Cited by 28
“from interventions aimed at preventing development and progression of CKD and diabetes mellitus [44], but we are”
MethodSun, Z., Yang, Y., Wu, J., Wang, M.-C., Chang, C., & Lu, F. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv385 · Cited by 29
“7% among US adults with prediabetes [15].”
Dong, W., Tse, E. T. Y., Mak, I. L., Wong, C. K. H., Wan, E. Y. F., Tang, E. H. M., Chin, W. Y., Bedford, L. E., Yu, E. Y. T., Ko, W. K. W., et al. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13790 · Cited by 27
El-Eshmawy, M. M., El-Hafez, H. A. A., Elshabrawy, W. O., & Aal, I. A. A. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.6.450 · Cited by 30
“, from 6% in normoglycaemia, to 10% in IFG and 29% in undiagnosed diabetes or diagnosed diabetes [8].”
BackgroundVisceral Adiposity Index was a useful Predictor of Prediabetes
Gu, D., Ding, Y., Zhao, Y., & Qu, Q. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-120440 · Cited by 29
Vieira, M. B., Neves, J. S., Leitão, L., Baptista, R. B., Magriço, R., Dias, C. V., Oliveira, A. B. F. D., Carvalho, D. M., & Causland, F. R. M. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00073 · Cited by 28
Moshkovits, Y., Rott, D., Chetrit, A., & Dankner, R. S. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01284-9 · Cited by 29
Predictors of diabetic nephropathy
Gaballa, M., & Farag, Y. M. K. (2012) · Open Medicine · doi:10.2478/s11536-012-0055-3 · Cited by 26
“Kidney disease represents an epic complication in diabetics as reflected by CKD prevalence reaching approximately 40% [4] and nephropathy representing one of the most common microvascular complications in type 2 diabetes (Figure 1) [5].”
Wang, D., Fang, R., Han, H., Zhang, J., Chen, K., Fu, X., He, Q., & Yang, Y. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13685 · Cited by 25
Diabetic Kidney Disease: From Pathogenesis to Novel Treatment Possibilities
Aboolian, A., Urner, S., Roden, M., Jha, J. C., & Jandeleit-Dahm, K. A. M. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2021_576 · Cited by 28
Aboelnasr, M. S., Shaltout, A., AlSheikh, M., Abdelhameed, A., & Elrefaey, W. (2020) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.279940 · Cited by 25
“7% of adults with previously undiagnosed DM had CKD.(20) This rate is higher than that reported for the United Kingdom Prospective Diabetes Study (UKPDS) population, wherein the prevalence was 25 and 5% for microalbuminuria and macroalbuminuria, respectively.”
ResultInfluentialChen, G., Yang, M., Chen, B., Song, Y., Zhang, W., & Zhang, Y. (2016) · Food & Function · doi:10.1039/c6fo01319h · Cited by 24
Lullo, L. D., Mangano, M., Ronco, C., Bàrbera, V., Pascalis, A. D., Bellasi, A., Russo, D., Iorio, B. R. D., & Cozzolino, M. G. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.03.005 · Cited by 25
“About 40% of patients with (diagnosed or not) diabetes mellitus has an advanced stage of kidney disease [8], often because of serious deficiencies in the management of the disease itself.”
BackgroundAgu, U., Agu, M. C., & Nnaji, G. A. (2015) · Epidemiology Reports · doi:10.7243/2054-9911-3-4 · Cited by 25
“Studies have shown that many people with undiagnosed DM already have complications such as chronic kidney disease, heart failure, retinopathy and neuropathy [7-9].”
BackgroundHypertension Control and Antihypertensive Therapy in Patients With Chronic Kidney Disease
Unni, S. K., White, K., Goodman, M. J., Ye, X., Mavros, P., Bash, L. D., & Brixner, D. L. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu215 · Cited by 24
Prediabetes, Prehypertension … Is It Time for Pre-CKD?
Curhan, G. C. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01650210 · Cited by 23
Liao, Y., Tsai, W., Chiu, L.-T., & Kung, P. (2023) · Health Policy · doi:10.1016/j.healthpol.2023.104917 · Cited by 27
Yan, M., Fu, Z., Qin, T., Wu, N., Lv, Y., Wei, Q., Jiang, H., & Yin, P. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12662 · Cited by 21
“Prediabetes is also associated with an increased risk of cardiovascular diseases, chronic kidney disease, and mortality.(1,3,4) In 2010, according to American Diabetes Association (ADA) criteria,(1) the prevalence of prediabetes in Chinese adults (aged ≥18 years) was 50.”
BackgroundThe Risk Threshold for Hemoglobin A1c Associated With Albuminuria: A Population-Based Study in China
Lian, H., Wu, H., Ning, J., Lin, D., Huang, C., Li, F., Liang, Y. J., Qi, Y., Ren, M., Yan, L., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.673976 · Cited by 26
Grandfils, N., Detournay, B., Attali, C., Joly, D. A., Simon, D., Vergès, B. L., Toussi, M., Briand, Y., & Delaitre, O. (2013) · International Journal of Endocrinology · doi:10.1155/2013/640632 · Cited by 22
“Distributed under a Creative Commons Attribution| 4.0 International License Glucose Lowering Therapeutic Strategies for Type 2 Diabetic Patients with Chronic Kidney Disease in Primary Care Setting in France: A Cross-Sectional Study N. Grandfils, B. Detournay, C. Attali, D. Joly, D. Simon, B.…”
MethodInfluentialAlbu, J., Sohler, N., Li, R., Li, X., Young, E., Gregg, E. W., & Ross‐Degnan, D. (2017) · Diabetes Care · doi:10.2337/dc16-2133 · Cited by 24
“Efficacious treatments exist and the consequences of untreated T2DM can be severe (2,3).”
BackgroundZhao, K., Yang, S., Wang, H., Chen, K., Lu, Z.-H., & Mu, Y. (2018) · Journal of Diabetes Research · doi:10.1155/2018/1031939 · Cited by 21
“Prediabetes is an important risk factor for diabetes [3] and many other diseases, such as cardiovascular diseases (CVD) [4], stroke [5], and nephropathy [6].”
BackgroundKolb, J. M., Kitos, N. R., Ramachandran, A., Lin, J. J., & Mann, D. M. (2014) · Journal of Bioinformatics and Diabetes · doi:10.14302/issn.2374-9431.jbd-13-312 · Cited by 23
Mendez, C. E., Walker, R. J., Eiler, C., Mishriky, B. M., & Egede, L. E. (2019) · Postgraduate Medicine · doi:10.1080/00325481.2019.1643635 · Cited by 22
“and that has been validated in NHANES participants with diabetes in the past [25].”
BackgroundPlasma glucose and hemoglobin A 1c for the detection of diabetes in C hinese adults
Xu, Y., Zhao, W., Wang, W., Bi, Y., Li, J., Mi, S., Xu, M., Lu, J., Wang, T., Li, M., et al. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12305 · Cited by 23
Gottwald‐Hostalek, U., & Gwilt, M. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2101805 · Cited by 22
Heerspink, H. J. L., Oberbauer, R. W., Perco, P., Heinzel, A., Heinze, G., Mayer, G. J., & Mayer, B. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv210 · Cited by 20
“In the Bardoxolone Methyl Evaluation in patients with CKD and type 2 diabetes mellitus: the Occurrence of Renal Events (BEACON) trial patients with a brain natriuretic peptide (BNP) > 200 pg/ mL or previous heart failure were at highest risk of heart failure [23].”
BackgroundConsensus on the Prevention of Type 2 Diabetes in Chinese Adults
Tong, Y.-Z., Tong, N., Teng, W., Mu, Y., Zhao, J., Shan, Z., & Ning, G. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.200532 · Cited by 21
Fagg, J., & Valabhji, J. (2018) · Diabetic Medicine · doi:10.1111/dme.13867 · Cited by 24
Warning signals of elevated prediabetes prevalence in the modern Iranian urban population
Barati, S., Sadeghipour, P., Ghaemmaghami, Z., Mohebbi, B., Baay, M., Alemzadeh‐Ansari, M. J., Hosseini, Z., Karimi, Y., Malek, M., Maleki, M., et al. (2021) · Primary care diabetes · doi:10.1016/j.pcd.2021.04.002 · Cited by 22
Simmons, R. K., Borch‐Johnsen, K., Lauritzen, T., Rutten, G. E. H. M., Sandbæk, A., van den Donk, M., Black, J. A., Tao, L., Wilson, E., Davies, M. J., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20640 · Cited by 23
Biomarkers of vascular complications in type 2 diabetes
Tremblay, J., & Hamet, P. (2014) · Metabolism · doi:10.1016/j.metabol.2014.10.032 · Cited by 22
Zemplényi, A., Sághy, E., Kónyi, A., Szabó, L., Wittmann, I., & Laczy, B. (2023) · International Journal of Public Health · doi:10.3389/ijph.2023.1605635 · Cited by 19
“5%) well-approximated the prevalence data known for CKD-associated DM in the literature (5, 27, 28).”
BackgroundEthnic differences in the development of albuminuria: the DISTANCE study.
Choi, A. I., Karter, A. J., Liu, J. Y., Young, B. A., Go, A. S., & Schillinger, D. (2011) · PubMed · Cited by 19
Ham, Y. R., Lee, E. J., Kim, H.-R., Jeon, J. W., Na, K. R., Lee, K. W., & Choi, D. E. (2023) · Diagnostics · doi:10.3390/diagnostics13030515 · Cited by 24
“5% of patients with T2DM [4], and its prevalence in patients with T2DM is three times higher than that in those without DM [5].”
BackgroundLee, L. T., Alexandrov, A. W., Howard, V. J., Kabagambe, E. K., Hess, M. A., McLain, R. M., Safford, M. M., & Howard, G. (2014) · Preventive Medicine · doi:10.1016/j.ypmed.2014.02.013 · Cited by 22
“Other major adverse effects of pre-diabetes include microvascular complications, and cardiovascular disease (Anon, 2007; Coutinho et al., 1999; Plantinga et al., 2010)”
BackgroundStatin Use in Patients with Diabetes and Kidney Disease: The Japanese Experience
Koya, D., & Campese, V. M. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.16261 · Cited by 19
Identifying prediabetes – Is it beneficial in the long run?
Ghody, P., Shikha, D., Karam, J., & Bahtiyar, G. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.03.022 · Cited by 18
IQGAP1 mediates podocyte injury in diabetic kidney disease by regulating nephrin endocytosis
Liu, Y., Su, H., Ma, C., Ji, D., Zheng, X.-L., Wang, P., Zheng, S., Wang, L., Wang, Z., & Xu, D. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.03.009 · Cited by 18
Zhang, H., Qi, D., Gu, H., Wang, T., Wu, Y., Li, J., Ni, J., Liu, J., Tu, J., Ning, X., et al. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13095 · Cited by 18
Phuphuakrat, A., Nimitphong, H., Reutrakul, S., & Sungkanuparph, S. (2020) · AIDS Research and Therapy · doi:10.1186/s12981-020-00284-1 · Cited by 18
Wong, C. K. H., Siu, S., Wan, E. Y. F., Jiao, F., Yu, E. Y. T., Fung, C. S. C., Wong, K.-W., Leung, A. Y. M., & Lam, C. L. K. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12310 · Cited by 18
Aladeniyi, I., Adeniyi, O. V., Fawole, O. I., Adeolu, M., Goon, D. T., Ajayi, A. I., & Iruedo, J. (2017) · The Open Public Health Journal · doi:10.2174/1874944501710010167 · Cited by 22
Relation of adipose tissue insulin resistance to prediabetes
Wen, J., Cai, X., Zhang, J., Jiang, J., Li, W., Liu, G., Wang, M., Gaisano, H. Y., Pan, Y., & He, Y. (2020) · Endocrine · doi:10.1007/s12020-020-02186-8 · Cited by 23
Hung, C., Zhen, Y., Niu, S., Lin, K., Lin, H. Y., Lee, J., Chang, J., & Kuo, I. (2022) · Biomedicines · doi:10.3390/biomedicines10081858 · Cited by 17
Chen, H.-W., Liu, K., Cao, B., Zhong, Q., Zhou, R., Li, L., Wang, S.-A., Wei, Y., Liu, H., & Wu, X. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02284-1 · Cited by 18
Weir, M. R. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15764 · Cited by 18
Larsen, A. U., Grimnes, G., & Jorde, R. (2017) · Osteoporosis International · doi:10.1007/s00198-017-4222-x · Cited by 18
“Such modest disturbances of glucose metabolism may increase the risk of complications traditionally attributed to T2DM, such as retinopathy, nephropathy, myocardial infarctions, and stroke, and both macro and microvascular damage appear to precede the onset of overt disease [5, 6].”
BackgroundPrediabetes and diabetes are both risk factors for adverse outcomes in infective endocarditis
Wei, X., Liu, Y. ‐., Huang, J. ‐., Chen, X. ‐., Yu, D., Tan, N., Chen, J. ‐., & He, P. (2018) · Diabetic Medicine · doi:10.1111/dme.13761 · Cited by 18
McEwan, P. C., Morgan, A. R., Boyce, R., Green, N., Song, B., Huang, J., & Bergenheim, K. (2022) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2022.21385 · Cited by 19
Sosibo, A. M., Mzimela, N. C., Ngubane, P. S., & Khathi, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278347 · Cited by 21
“These risk factors are well documented in the literature to be associated with the development of diabetes [24, 43, 44].”
BackgroundLi, C., Wen, X., Pavkov, M. E., Zhao, G., Balluz, L. S., Ford, E. S., Williams, D. E., & Gotway, C. A. (2014) · American Journal of Nephrology · doi:10.1159/000360184 · Cited by 17
Self-citationLinagliptin as add-on therapy to insulin for patients with type 2 diabetes
Hocher, B., von Websky, K., & Reichetzeder, C. (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s40035 · Cited by 17
Drug therapies to delay the progression of chronic kidney disease
Ward, F. L., Holian, J., & Murray, P. T. (2015) · Clinical Medicine · doi:10.7861/clinmedicine.15-6-550 · Cited by 17
Laker, R. C., Egolf, S., Will, S., Lantier, L., McGuinness, O. P., Brown, C. L., Bhagroo, N. V., Oldham, S. N., Kuszpit, K. K., Alfaro, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59773-4 · Cited by 18
“…failure of pancreatic β -cells to meet the insulin secretory demand, resulting in poor glycaemic control associated with a multitude of co-morbidities, including metabolic dysfunction-associated steatotic liver disease (MASLD) 1,2 , diabetic kidney disease 3,4 , and cardiovascular dysfunction 5 .”
Park, S. K., Ryoo, J., Oh, C., Choi, J., Choi, Y., Lee, K. O., & Jung, J. Y. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.002 · Cited by 18
Ustulin, M., Rhee, S. Y., Chon, S., Ahn, K. K., Lim, J. E., Oh, B., Kim, S., Baik, S. H., Park, Y., Nam, M. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34411-w · Cited by 16
Bruun-Rasmussen, N. E., Napolitano, G. M., Kofoed‐Enevoldsen, A., Bojesen, S. E., Ellervik, C., Rasmussen, K., Jepsen, R., & Lynge, E. (2020) · BMC Public Health · doi:10.1186/s12889-020-09791-2 · Cited by 17
Fukuma, S., Sasaki, S., Taguri, M., Goto, R., Misumi, T., Saigusa, Y., & Tsugawa, Y. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021050664 · Cited by 17
Zeidalkilani, J., Milhem, Y. A., Shorafa, R. N., Taha, S., Koni, A. A., Al‐Jabi, S. W., & Zyoud, S. H. (2024) · BMC Nephrology · doi:10.1186/s12882-024-03674-z · Cited by 15
Outcomes of Kidney Donors With Impaired Fasting Glucose
Hebert, S. A., Murad, D. N., Nguyen, D. T., Graviss, E. A., Adrogue, H. E., Matas, A. J., & Ibrahim, H. N. (2021) · Transplantation · doi:10.1097/tp.0000000000003665 · Cited by 15
Association between gut microbiota and prediabetes in people living with HIV
Jayanama, K., Phuphuakrat, A., Pongchaikul, P., Prombutara, P., Nimitphong, H., Reutrakul, S., & Sungkanuparph, S. (2022) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2022.100143 · Cited by 16
Zee, B. C.-Y., Lee, J., Lai, M., Chee, P., Rafferty, J., Thomas, R., & Owens, D. R. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-002914 · Cited by 17
Association of prediabetes-associated single nucleotide polymorphisms with microalbuminuria
Choi, J. W., Moon, S., Jang, E. J., Lee, C. H., & Park, J.-S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171367 · Cited by 16
Managing the Course of Kidney Disease in Adults With Type 2 Diabetes: From the Old to the New
Goldenberg, R., Berall, M. J., Chan, C. T., Cherney, D. Z. I., Lovshin, J. A., McFarlane, P. A., Senior, P. A., Verma, S., & Weinstein, J. J. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.06.008 · Cited by 17
Liu, Y., Guo, H., Wang, Q., Chen, J., Xuan, Y., Xu, J., Liu, Y., Sun, K., Gao, Q., Sun, Z., et al. (2021) · Primary care diabetes · doi:10.1016/j.pcd.2021.12.009 · Cited by 15
Primary Care–Based Health Coaching for the Management of Prediabetes
Sherman, R. P., & Ganguli, I. (2017) · American Journal of Lifestyle Medicine · doi:10.1177/1559827617702074 · Cited by 14
Yadav, R., Jain, N., Raizada, N., Jhamb, R., Rohatgi, J., & Madhu, S. V. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102226 · Cited by 14
Shahzadi, A., Sönmez, M. I., KÖSE, Ç., Oktan, B., Alagöz, S., Sönmez, H., Hussain, A., & Akkan, A. G. (2022) · Medicina · doi:10.3390/medicina58020183 · Cited by 14
“The literature shows that morbidities and mortalities are associated with CKD as this population has an increased risk of diabetes and cardiovascular events [5,6].”
BackgroundMarkers of Sleep-Disordered Breathing and Prediabetes in US Adults
Alshaarawy, O., Teppala, S., & Shankar, A. (2012) · International Journal of Endocrinology · doi:10.1155/2012/902324 · Cited by 14
“[6, 7], as well as cardiovascular disease [28], and chronic kidney disease [29], and (2) from a risk stratification point of view, our results support the notion that subjects with clustering of ≥3 SDB symptoms should be screened for prediabetes.”
ResultThe association of glucose metabolism and kidney function in middle-aged adults
Schroijen, M. A., de Mutsert, R., Dekker, F. W., de Vries, A. P. J., de Koning, E. J. P., Rabelink, T. J., Rosendaal, F. R., & Dekkers, O. M. (2021) · Clinical Kidney Journal · doi:10.1093/ckj/sfab074 · Cited by 15
“First, in a US study [9], many patients had no insurance (8.”
BackgroundResultInfluentialPathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_8 · Cited by 16
Sato, Y. Z., Yano, Y., Fujimoto, S., Konta, T., Iseki, K., Moriyama, T., Yamagata, K., Tsuruya, K., Yoshida, H., Asahi, K., et al. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs324 · Cited by 13
“Subjects with prediabetes were reported to have higher incidence of hypertension and obesity, and to be older than subjects with normal glucose tolerance [10, 11].”
BackgroundMethodSümbül, H. E., Koc, A., & Gülümsek, E. (2019) · Singapore Medical Journal · doi:10.11622/smedj.2019052 · Cited by 14
Kountz, D. S. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0071-y · Cited by 14
“The National Kidney Foundation (NKF) Kidney Disease Outcomes Quality Initiative (KDOQI) defines CKD by the presence of kidney damage or a glomerular filtration rate (GFR) \60 mL/ min/1.73 m2 for 3 months or more [18].”
BackgroundInfluentialChen, Z., Wu, S., Huang, J., Yuan, J., Chen, H., & Chen, Y. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12958 · Cited by 13
Hieshima, K., Suzuki, T., Sugiyama, S., Kurinami, N., Yoshida, A., MIYAMOTO, F., Kajiwara, K., Jinnouchi, T., & Jinnouchi, H. (2018) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3400w · Cited by 13
“Diabetes was also shown to be a risk factor for CKD, and patients with diabetes have three to four times more CKD complications compared with those without diabetes [13].”
BackgroundWang, H., Yan, W., Dou, J., Lü, Z., Wang, B., & Mu, Y. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.202741 · Cited by 12
Strategies for the Prevention of Coronary Artery Disease Complications: Can We Do Better?
Ambrose, J. A., & Najafi, A. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.04.006 · Cited by 13
García‐Donaire, J. A., Segura, J., Cerezo, C., & Ruilope, L. M. (2011) · Blood Pressure · doi:10.3109/08037051.2011.602878 · Cited by 14
“Chronic kidney disease (CKD) is prevalent in people with diabetes; a recent analysis of NHANES data found that 39.6% of people with diagnosed diabetes, 41.7% of those with undiagnosed diabetes and 17.7% of those with prediabetes had CKD (1).”
BackgroundInfluentialSurana, S. P., Kumar, N., Vasudeva, A., Shaikh, G. G., Jhaveri, K. D., Shah, H. H., Malieckal, D. A., Fogel, J., Sidhu, G., & Rubinstein, S. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0443-7 · Cited by 12
Li, W., Wang, A., Jiang, J., Liu, G., Wang, M., Li, D., Wen, J., Mu, Y., Du, X., Gaisano, H. Y., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000955 · Cited by 12
Prevalence of diabetic kidney disease in prediabetes
Branda, J. I. F., de Almeida-Pititto, B., & Ferreira, S. R. G. (2019) · Obesity Medicine · doi:10.1016/j.obmed.2019.100105 · Cited by 14
Metadata
- Authors
- Plantinga, L. C., Crews, D. C., Coresh, J., Miller, E. R., Saran, R., Yee, J., Hedgeman, E., Pavkov, M., Eberhardt, M. S., Williams, D. E., & Powe, N. R.
- Affiliations
- San Francisco General Hospital (US)
- Johns Hopkins University (US)
- University of Michigan (US)
- Henry Ford Health (US)
- Centers for Disease Control and Prevention (US)
- University of California, San Francisco (US)
- ORCID
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2010-04
- Volume
- 5
- Issue
- 4
- Pages
- 673-682
- ISSN
- 1555-9041 (ISSN-L)
- PMC
- PMC2849697
- OpenAlex
- W2128714303
- Cited by
- 408
- References
- 28
- Citations by year
- 2026: 12 · 2025: 28 · 2024: 24 · 2023: 25 · 2022: 18 · 2021: 30 · 2020: 28 · 2019: 29 · 2018: 32 · 2017: 26 · 2016: 34 · 2015: 31 · 2014: 27 · 2013: 28 · 2012: 15
- FWCI
- 15.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (K24 DK02643, K24DK002643)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- chronic kidney disease, undiagnosed diabetes, prediabetes, diabetes prevalence, albumin-creatinine ratio, estimated glomerular filtration rate, NHANES, diabetes screening
- MeSH terms
- Adult, Albuminuria, Blood Glucose, Chronic Disease, Creatinine, Diabetes Mellitus, Fasting, Female, Glomerular Filtration Rate, Health Surveys, Humans, Kidney Diseases, Male, Mass Screening, Middle Aged, Prediabetic State, Predictive Value of Tests, Surveys and Questionnaires, United States, Biomarkers, Comorbidity, Prevalence, Chi-Square Distribution, Logistic Models, Early Diagnosis, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.